Evidence map›Paper›PMID 37336203›Full record

ArticleNanotechnology2023

Sneaking in SpyCatcher using cell penetrating peptides for

James Tyler, Corie Y Ralston, Behzad Rad

Open access · hybridAbstract read
In one paragraph

Article in Nanotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

James TylerMolecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States of America.ORCID 0000-0001-7378-2347
Corie Y RalstonMolecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States of America.
Behzad RadMolecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States of America.ORCID 0000-0001-6531-9168
Lawrence Berkeley National Laboratory · US

Funding

Development of high-dose time-resolved x-ray footprinting technologies to enable the next level of structural analysis for challenging biological problemsR01GM126218 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI RALSTON, CORIE Y · 2018 to 2025
$3.4M
New assay method for pinpointing structural features in amyloid oligomer formationR21AG072478 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI RALSTON, CORIE Y · 2021 to 2021
$559k
NIA NIH HHS R21 AG072478NIGMS NIH HHS R01 GM126218
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell-Penetrating PeptidesBiological TransportProteinsCell-Penetrating PeptidesProteinscovalent chemistryprotein materialsspyCatchersuper-resolution imaging

Identifiers

PMID37336203
PMCPMC10396330
OpenAlexW4381161913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.